Thumbnails similares a Why Glucose Alone Isn't Enough: The Future of Ketone Monitoring in Diabetes

20 vecinos (thumb_512) · 475 views · HCPLive · Estados Unidos


★	Why Glucose Alone Isn't Enough: The Future of Ketone Monitoring in Diabetes	HCPLive @hcplivenews	475	Estados Unidos
5	Survodutide Shows Fat Mass Loss, Liver Fat Reductions in Patients With Obesity Without T2D	HCPLive @hcplivenews	1.6K	Estados Unidos	73
11	Retatrutide Provides Substantial Weight Loss in Patients With Obesity or Overweight	HCPLive @hcplivenews	1.1K	Estados Unidos	70
20	The World’s First Dual Glucose-Ketone Monitor Receives Clearance in Europe	HCPLive @hcplivenews	313	Estados Unidos	67
7	Is Continuous Ketone Monitoring Future of Diabetes Care?	HCPLive @hcplivenews	270	Estados Unidos	71
9	Diabetes Dialogue: Tegoprubart and Freedom from Insulin in Type 1 Diabetes	HCPLive @hcplivenews	143	Estados Unidos	70
1	FIND-CKD Expands Finerenone Evidence Beyond Diabetic CKD, With Rajiv Agarwal, MD	HCPLive @hcplivenews	131	Estados Unidos	78
16	Can Type 2 Diabetes Be Reversed? \| Type 1 vs Type 2 Diabetes Explained	Pristyn Care Surgeries @pristyncaresurgeries	128	India	69
18	Overcoming Barriers to Diagnosis of CKD in Type 2 Diabetes	Bayer Global @bayerglobal	116	Alemania	68
12	Insulin Icodec Dosing Strategies for Type 2 Diabetes	HCPLive @hcplivenews	105	Estados Unidos	70
10	VESALIUS-CV: Evolocumab Prevents Cardiovascular Disease in High-Risk Diabetes	HCPLive @hcplivenews	96	Estados Unidos	70
6	Improving GLP-1 Adherence in Patients With Diabetes, With Vivian Fonseca, MD	HCPLive @hcplivenews	91	Estados Unidos	72
3	GLP-1s Move Beyond Diabetes as Core Kidney-Protective Therapy	HCPLive @hcplivenews	80	Estados Unidos	73
13	How a Nephrologist Diagnoses and Manages Chronic Kidney Disease	HCPLive @hcplivenews	70	Estados Unidos	70
8	GLP-1 Discontinuation in Type 2 Diabetes: What Happens When Patients Stop?	HCPLive @hcplivenews	64	Estados Unidos	70
19	Diabetes Dialogue: Teplizumab, Stelo, and Inhaled Insulin Afrezza for Pediatric Patients	HCPLive @hcplivenews	53	Estados Unidos	67
14	Mifepristone Improves HbA1c, Weight in Poorly Controlled T2D, Regardless of GLP-1 Treatment	HCPLive @hcplivenews	46	Estados Unidos	69
15	Screening for Type 1 Diabetes in Adults: What Needs to Change	HCPLive @hcplivenews	42	Estados Unidos	69
2	Does Insulin Resistance Harm the Lungs? CT Data Offers New Clues \| ATS 2026	HCPLive @hcplivenews	25	Estados Unidos	74
4	What Clinicians Should Know About Diet and Skin Disease, With Rajani Katta, MD	HCPLive @hcplivenews	19	Estados Unidos	73
17	How Should Clinicians Address the Link Between Atopic Dermatitis and Allergy? With Jay Lieberman, MD	HCPLive @hcplivenews	13	Estados Unidos	68